Announcements
Sidley Represents EDBI in Automera’s US$16M Series A Financing
October 2, 2023
Sidley represented EDBI in its investment in Automera, a company developing an autophagy drug designed to target chimera small molecules (AUTACs), in its US$16M Series A financing round.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
The round was co-led by U.S.-based Accelerator Life Sciences Partners (ALSP) and Temasek-backed ClavystBio, with participation of Xora Innovation and other investors.
The Sidley team was led by corporate partner Andrew Harper, and included private equity partner Parthiv Rishi, senior managing associate Eldon Chan, and associates Ryan Lim, and Yasmeen A. Sayyah.
Contacts
Offices
Capabilities
Suggested News & Insights
Sidley Represents Simcere in €1 Billion Licensing and Collaboration Agreement With Boehringer IngelheimJanuary 29, 2025Sidley Represents Duetti in Series C FinancingJanuary 28, 2026Sidley Represents Primemas in US$72 Million Series B FinancingJanuary 23, 2026Sidley Ranked in Chambers Greater China Region 2026January 15, 2026Korea Night @ JPM 2026Wednesday, January 14, 2026Sidley Blockchain Bulletin - 2026 Business, Legal and Regulatory OutlookJanuary 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory